Masanobu Yamazato Selected Research

Masanobu Yamazato Research Topics

7	Hypertension (High Blood Pressure) 10/2021 - 02/2005
2	Hypersensitivity (Allergy) 01/2020 - 10/2002
2	Inflammation (Inflammations) 10/2018 - 01/2018
2	Fibrosis (Cirrhosis) 03/2014 - 02/2008
2	Stroke (Strokes) 03/2014 - 04/2007
2	Diabetes Mellitus 01/2011 - 12/2002
1	Endocarditis 01/2020
1	IGA Glomerulonephritis (IGA Nephropathy) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Proteinuria 01/2018
1	Hyperuricemia 08/2016
1	Acute Lung Injury 08/2009
1	Pulmonary Hypertension 08/2009
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2008
1	Hypertrophy 02/2008
1	Menorrhagia 10/2002
1	Glomerulonephritis 10/2002
1	Abdominal Pain (Pain, Abdominal) 10/2002
1	Hypercholesterolemia 05/2002
1	Amyloidosis 03/2002
1	Citrullinemia 01/2002
1	Coma (Comas) 01/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2002
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2002

4	Angiotensin Receptor AntagonistsIBA 01/2018 - 02/2008
3	candesartanIBA 01/2018 - 02/2008
2	SaltsIBA 10/2021 - 02/2008
2	Angiotensin IIIBA 10/2018 - 04/2007
1	PotassiumIBA 10/2021
1	Daptomycin FDA Link 01/2020
1	Vancomycin FDA LinkGeneric 01/2020
1	Type 1 Angiotensin ReceptorIBA 10/2018
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2018
1	MonocrotalineIBA 01/2018
1	SteroidsIBA 01/2018
1	Prednisolone (Predate)FDA LinkGeneric 01/2018
1	Allopurinol (Remid)FDA LinkGeneric 08/2016
1	Xanthine OxidaseIBA 08/2016
1	Febuxostat FDA Link 08/2016
1	Hydralazine (Apresoline)FDA LinkGeneric 03/2014
1	AntioxidantsIBA 03/2014
1	tempolIBA 03/2014
1	Proteins (Proteins, Gene)FDA Link 03/2014
1	Superoxide DismutaseIBA 03/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2014
1	ThiazidesIBA 01/2011
1	Hemoglobins (Hemoglobin)IBA 01/2011
1	CytokinesIBA 08/2009
1	Angiotensin-Converting Enzyme 2IBA 08/2009
1	EnzymesIBA 08/2009
1	Pioglitazone (Actos)FDA Link 02/2008
1	2,4-thiazolidinedione (thiazolidinedione)IBA 02/2008
1	azelnidipineIBA 04/2007
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 02/2005
1	nafamostatIBA 10/2002
1	AnticoagulantsIBA 10/2002
1	Serum AlbuminIBA 05/2002
1	Glycerol (Glycerine)FDA LinkGeneric 01/2002
1	AmmoniaIBA 01/2002
1	CitrullineIBA 01/2002

5	Renal Dialysis (Hemodialysis) 01/2020 - 01/2002
4	Therapeutics 01/2018 - 01/2002
1	Tonsillectomy 01/2018
1	Intravenous Administration 04/2007
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2002
1	Liver Transplantation 01/2002